SUPINTRO
Class D (high risk) · MDIR-0009569 · Gentek pharma
DRAP REGISTERED MEDICAL DEVICE
SUPINTRO (Absorbable Hyaluronic Acid Intraarticular Gel Implant + L-Proline/Glycine/N-Ac etylglucosamine) Intraarticular injection (Active ingredient: Hyaluronic Acid) is registered with DRAP under number MDIR-0009569 as a Class D (high risk) medical device, imported. The listed holder is Gentek pharma. It is listed as valid until 11 Jun 2030.
Screening result
MDIR-0009569 · the class is taken from DRAP's list for this number
DRAP registered Class B/C/D list, 28 Aug 2025
That list covers manually issued licences only. Ask for a copy of the establishment licence.
| Device | SUPINTRO (Absorbable Hyaluronic Acid Intraarticular Gel Implant + L-Proline/Glycine/N-Ac etylglucosamine) Intraarticular injection (Active ingredient: Hyaluronic Acid) |
|---|---|
| Class | D |
| Listed holder | Gentek pharma |
| Holder address | Sultana Apartments, Ground Floor, A Block, Satellite Town, Rawalpindi. |
| Manufacturing site | M/s ERC Biyoteknoloji SAN VE Dis TIC A.S Ahmet yesevi mah kerem sok ablok no.9 1B01 Pendik/Istanbul-Turkey |
| Issued | 12 Jun 2025 |
| Renewal date | 11 Jun 2030 |
Specifications
No supplier specifications yet.
Supplier of this device? Add specifications (free during launch)
Sign in or create a free account to add specifications.
Screened 21 Nov 2026, 08:32 (Pakistan time). A screening aid, not an official DRAP verification.
More devices from this holder
Other DRAP registrations and enlistments listed for the same company.
| MDIR-0009568 | VISCOART (Absorbable Hyaluronic Acid Intraarticular Gel Implant + L-Proline) Intrarticular injection | Class D |
Corrections
Is something on this page wrong? Report a correction
Corrections are checked against the evidence before anything changes on this page.
Screen another number
Source: DRAP's published provisional lists. A screening aid, not an official DRAP verification; confirm with DRAP and the supplier's original documents.
